1 – 10 of 56
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer : A Step in the Right Direction but Still a Long Way To Go.
- European Association of Urology Guidelines Office : How We Ensure Transparent Conflict of Interest Disclosure and Management
- Re : Improving Management of Upper Tract Urothelial Carcinoma
- Re : 17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort
- Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations : Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”
- Preventing Parastomal Hernia After Ileal Conduit by the Use of a Prophylactic Mesh : A Randomised Study
- 2019
-
Systematic Review of Combination Drug Therapy for Non-neurogenic Lower Urinary Tract Symptoms
Serati, Maurizio ; Andersson, Karl-Erik LU
; Dmochowski, Roger
; Agrò, Enrico Finazzi
; Heesakkers, John
; Iacovelli, Valerio
; Novara, Giacomo
; Khullar, Vik
and Chapple, Christopher
(2019)
In European Urology
75(1).
p.129-168
Mark
- Reasons for Discontinuing Active Surveillance : Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium
- European Association of Urology Guidelines on Renal Cell Carcinoma : The 2019 Update
- Re : Tuan Zea Tan, Mathieu Rouanne, Kien Thiam Tan, Ruby Yun-Ju Huang, Jean-Paul Thiery. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors. Eur Urol 2019;75:423–32